The practising clinician treating a patient with metastatic clear cell renal cell carcinoma
(CCRCC) faces a difficult task of choosing the most appropriate therapeutic regimen in a …

Cancer has become increasingly common worldwide, being the second leading cause of
death and an important barrier to increasing life expectancy in all countries in the XXI …

Background Patients with metastatic renal cell carcinoma (mRCC) treated with systemic
therapy sometimes progress at limited sites. The best treatment approach for patients with …

We examined the role of differentially expressed autophagy-related genes (DEARGs) in
clear cell Renal Cell Carcinoma (ccRCC) using high-throughput RNA-seq data from The …

Background Recent studies have demonstrated that immune-associated genes (IAGs) play
an important role in the occurrence and progression of clear renal clear cell carcinoma …

Renal cell carcinoma (RCC) remains one of the most lethal urinary tumors in East Asia
despite great advancements in treatment strategies in recent years. Ribosomal protein S20 …

Pyroptosis is a kind of programmed cell death triggered by the inflammasome. Growing
evidence has revealed the crucial utility of pyroptosis in tumors. However, the potential …

Background: Over the past few years, significant advancements have been achieved in the
front-line treatment of metastatic renal cell carcinomas (mRCCs). However, most patients will …

Metastasis-associated protein 2 (MTA2) was previously known as a requirement to maintain
malignant potentials in several human cancers. However, the role of MTA2 in the …

Background: Currently, there are no useful biomarkers or prognostic risk markers for the
diagnosis of kidney renal clear cell carcinoma (KIRC), although recent research has shown …